Panacea Life Sciences Holdings, Inc. Debt Conversion, Converted Instrument, Rate
Panacea Life Sciences Holdings, Inc. (PLSH) reported Debt Conversion, Converted Instrument, Rate of 4.99% for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentRate · last filed 2022-03-31
- Panacea Life Sciences Holdings, Inc. debt conversion, converted instrument, rate for fiscal 2021 was 4.99%.
| Period end | Debt Conversion, Converted Instrument, Rate 12 month |
|---|---|
| 2021-12-31 | 4.99% 10-K · filed 2022-03-31 |